4th Annual Conference of Movement Disorders Society of India (MDSICON 2019) welcomes submission of abstracts for original contribution to the field in the following scientific tracks:
- Movement Disorders topics, including, but not limited to, ataxia, chorea, dystonia, myoclonus, Parkinson’s disease, restless legs syndrome, spasticity, stereotypies, tics and tremors
- Basic science issues, including, but not limited to, genetics, neuroimaging, neuropharmacology, surgical therapy and transplantation
- Other less common clinical conditions
Participants are invited to submit original scientific abstracts for poster presentation provided that the abstracts have not been previously published as a full paper. If you have submitted your paper to a journal for publication, please ensure that the publication date will be after the congress.
Note that abstracts presented previously at national or international meetings can be submitted providing this is declared, but that we particularly welcome work not previously presented at other meetings. Authors are requested to conform to guidelines for submission of abstracts. Abstracts not conforming to the guidelines will not be referred for review. The abstracts must be submitted in English and must also be presented in that language. Abstracts will be reviewed by a panel of experts and, if accepted, may be selected for poster presentation (or may be rejected).
Notification of acceptance or rejection will be emailed to the submitting author at the email address supplied after the abstract review process.
General Abstract Guidelines:
- Abstracts must be no longer than 300 words including spaces and punctuation and title. It should be written regular Times New Roman, Font size 12.One table may be submitted with the abstract and will count towards the 300 words limit. No figures will be accepted.
- Completed abstracts must be submitted through the MDSICON (a link will be provided in your confirmation e-mail that you will receive after completing the online submission and payment process).
- Interim analysis for studies in progress will be considered; however, as with all abstracts, data analysis/summary must be included in the results section in order to support conclusions.
- Study titles should be neutral and when referring to drug names, generic names should be used as applicable.
- Abbreviations should only be used after first spelling out the words to be abbreviated within the abstract.
- Authors may serve as first authors on up to two abstracts, but may be co-authors on an unlimited number of other abstract submissions.
- Last date for abstract submission is 30th October 2018.
- Title (enter title in sentence case, with a capital letter on the first word and any proper nouns only, using bold, Times New Roman text, 12 point)
- Enter all author names (First Name Last Name) on the same line, in italics, Time New Roman text, 12 point, separated by comma
- Name of the affiliated institute/s
- Abstract should be structured and with the subheadings Introduction, Methods, Results, Conclusion
Poster sessions and presentations
One author or colleague must be present at your poster during the assigned poster session time (informed later) on the day of your presentation to explain your research and answer questions from viewers. Posters session assignments cannot be rescheduled. Posters displayed on a day or on a board to which it is not assigned will be removed without prior notice.
Registration and attendance
IMPORTANT: The presenting author should be registered for MDSICON 2019 at the time of presentation.
Online Abstract Submission